Literature DB >> 6631220

Cholesterol crystal formation and growth in model bile solutions.

M J Whiting, J M Watts.   

Abstract

Cholesterol monohydrate crystal formation was studied in supersaturated model bile solutions, containing unlabeled cholesterol, sodium cholate and soybean phosphatidylcholine, and tracer amounts of [3H]cholesterol. Solutions were either seeded with cholesterol crystals to initiate growth, or not seeded to allow self-nucleation and subsequent crystal growth to occur. Crystal growth at 37 degrees C was measured by two methods. First, radioactive cholesterol crystals were isolated by filtration, and the mass of cholesterol that had precipitated was calculated. In unseeded solutions, there was a long lag period before crystal growth was detected. This lag time was decreased by increases in the cholesterol concentration, temperature, and lipid concentration. In seeded solutions, crystal growth also was dependent on the cholesterol concentration, temperature, and lipid concentration. The second method used to measure crystal growth involved the Coulter Counter. At 37 degrees C, reproducible results were not obtained using unseeded solutions due to blocking of the counter aperture with large crystals. In seeded solutions, crystal growth could be measured as an increase in total particle volume. However, comparison of growth rate estimates from the Coulter Counter with those obtained radiochemically revealed poor agreement between the two methods. It is probable that the Coulter Counter is inaccurate in measuring the volume of cholesterol monohydrate crystals due to their anisometric shape.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631220

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

Review 1.  Cholesterol crystallisation in bile.

Authors:  P Portincasa; K J van Erpecum; G P Vanberge-Henegouwen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

2.  Autophagy links inflammasomes to atherosclerotic progression.

Authors:  Babak Razani; Chu Feng; Trey Coleman; Roy Emanuel; Haitao Wen; Seungmin Hwang; Jenny P Ting; Herbert W Virgin; Michael B Kastan; Clay F Semenkovich
Journal:  Cell Metab       Date:  2012-03-20       Impact factor: 27.287

3.  Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis.

Authors:  Ismail Sergin; Somashubhra Bhattacharya; Roy Emanuel; Emel Esen; Carl J Stokes; Trent D Evans; Batool Arif; John A Curci; Babak Razani
Journal:  Sci Signal       Date:  2016-01-05       Impact factor: 8.192

4.  Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis.

Authors:  Ismail Sergin; Trent D Evans; Xiangyu Zhang; Somashubhra Bhattacharya; Carl J Stokes; Eric Song; Sahl Ali; Babak Dehestani; Karyn B Holloway; Paul S Micevych; Ali Javaheri; Jan R Crowley; Andrea Ballabio; Joel D Schilling; Slava Epelman; Conrad C Weihl; Abhinav Diwan; Daping Fan; Mohamed A Zayed; Babak Razani
Journal:  Nat Commun       Date:  2017-06-07       Impact factor: 14.919

5.  Salvianolic acid B improves autophagic dysfunction and decreases the apoptosis of cholesterol crystal‑induced macrophages via inhibiting the Akt/mTOR signaling pathway.

Authors:  Mengqi Sun; Yun Ye; Yilan Huang; Wenxian Yin; Zhaolan Yu; Shurong Wang
Journal:  Mol Med Rep       Date:  2021-09-07       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.